Report – Analysis of 2021 U.S FDA 483 GMP Observations

Webinar – Bringing Innovation to Regulatory Intelligence from Ideation to Success

Report – Yes, Warehouses that Store and Distribute FDA Regulated Products Must Comply with Relevant GMPs

Report – UDI-related Issues in Form 483s: Where Should You Focus Mitigation Efforts?

Report – Analysis of FDA Drug GMP Warning Letters for FYs 2020 and 2021

Report – GMP Issues With COVID Vaccines and Drugs are Not New Concerns

Webinar – UDI | Aligning to a Single Approach

Redica Systems Announces $30M Series B

Redica Systems Announces $30M Series B Led by Savant Growth to Bring New Analytics and Compliance Platform to FDA-Regulated Life Sciences Companies Investment To Help Extend Lead in Quality and Regulatory Intelligence for FDA-regulated Industries PLEASANTON, CA, December 9, 2021 — Redica Systems, a cloud-based data intelligence platform serving FDA-regulated industries, announced it has secured […]

Report – The Current Pharmaceutical Quality Landscape

Webinar – Past, Present, and Future of Quality Culture
« Older Entries
Newer Entries »